Impact of Steady State Cobicistat and Darunavir/Cobicistat on the Pharmacokinetics and Pharmacodynamics of Oral Anticoagulants (Rivaroxaban, Apixaban) in Health Volunteers
Clinical trial NCT03864406 · COMPLETED
Trial details
- NCT number
- NCT03864406
- Sponsor
- National Institutes of Health Clinical Center (CC)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-04
- Primary completion
- 2022-12-10
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.